• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

黑质内注射蝇蕈醇后抗伤害感受在自我伤害行为中的作用评估。

Evaluation of the role of antinociception in self-injurious behavior following intranigral injection of muscimol.

作者信息

Frye G D, Baumeister A A, Crotty K, Newman K D, Kotrla K J

出版信息

Neuropharmacology. 1986 Jul;25(7):717-26. doi: 10.1016/0028-3908(86)90087-0.

DOI:10.1016/0028-3908(86)90087-0
PMID:2944027
Abstract

In rats, bilateral injection of muscimol (30-60 ng/site) into the medial substantia nigra zona reticulata exerted an antinociceptive effect in the hotplate and tail-flick tests. Injections of muscimol into the substantia nigra also induced intense stereotyped behavior and self-injurious behavior (SIB). Tail-flick and hindpaw-lick responses were inhibited between 30 and 120 min after muscimol, but recovered by 240 min. The antinociceptive responses were not due to motor impairment or ataxia induced by muscimol because a variety of highly-coordinated stereotyped behavioral responses, including rearing, sniffing, head bobbing and licking occurred concurrently. Injection of muscimol into the deep mesencephalic nucleus (DpMcN) also inhibited the tail-flick and hindpaw-lick responses and caused stereotyped behavior but did not induce self-injurious behavior. Injections of muscimol into the substantia nigra, angled (45 degrees) to avoid passing through the deep mesencephalic nucleus, still exerted antinociceptive activity and caused self-injurious behavior. Bilateral microinjections of baclofen (300 ng), 4,5,6,7-tetrahydroisoxazols (5,40c)pyridin-3-ol (THIP; 300 ng), sodium valproate + D,L-diaminobutyric acid (1 microgram), substance P (2.5 micrograms) or D-Pro2-D-Trp7.9-substance P (2.5 micrograms), all suppressed hindpaw-lick responses, although only THIP reduced tail-flick responses. None of these treatments evoked self-injurious behavior. Naloxone (10 mg/kg), picrotoxin (5 mg/kg) or atropine (10 mg/kg) injection of muscimol into the substantia nigra (60 ng) or a single pretreatment with p-chlorophenylalanine diethyl ester (PCPA; 500 mg/kg; 48 hr prior to muscimol) failed to suppress the hindpaw-lick response or self-injurious behavior. These results suggest that the injection of muscimol into the substantia nigra evokes a centrally-mediated antinociception which alone is not sufficient to induce self-injurious behavior. Both antinociception and self-injurious behavior after injection of muscimol into the substantia nigra appear unrelated to cholinergic, serotoninergic, or naloxone-sensitive nociceptive systems; however, the role of activation of gamma-aminobutyric acid (GABA) receptors in these actions of muscimol also remains to be clarified.

摘要

在大鼠中,向黑质网状带内侧双侧注射蝇蕈醇(30 - 60纳克/部位)在热板和甩尾试验中产生了镇痛作用。向黑质注射蝇蕈醇还会诱发强烈的刻板行为和自我伤害行为(SIB)。在注射蝇蕈醇后30至120分钟内,甩尾和后爪舔舐反应受到抑制,但在240分钟时恢复。这种镇痛反应并非由蝇蕈醇引起的运动障碍或共济失调所致,因为同时出现了多种高度协调的刻板行为反应,包括直立、嗅探、点头和舔舐。向中脑深部核(DpMcN)注射蝇蕈醇也会抑制甩尾和后爪舔舐反应,并引起刻板行为,但不会诱发自我伤害行为。向黑质注射蝇蕈醇时,呈一定角度(45度)以避免穿过中脑深部核,仍能发挥镇痛活性并导致自我伤害行为。双侧微量注射巴氯芬(300纳克)、4,5,6,7 - 四氢异恶唑并[5,4 - c]吡啶 - 3 - 醇(THIP;300纳克)、丙戊酸钠 + D,L - 二氨基丁酸(1微克)、P物质(2.5微克)或D - Pro2 - D - Trp7,9 - P物质(2.5微克),均能抑制后爪舔舐反应,不过只有THIP能降低甩尾反应。这些处理均未诱发自我伤害行为。向黑质(60纳克)注射蝇蕈醇后注射纳洛酮(10毫克/千克)、印防己毒素(5毫克/千克)或阿托品(10毫克/千克),或者在注射蝇蕈醇前用对氯苯丙氨酸二乙酯(PCPA;500毫克/千克;提前48小时)进行单次预处理,均未能抑制后爪舔舐反应或自我伤害行为。这些结果表明,向黑质注射蝇蕈醇会引发中枢介导的镇痛作用,而这种镇痛作用本身不足以诱发自我伤害行为。向黑质注射蝇蕈醇后的镇痛作用和自我伤害行为似乎与胆碱能、血清素能或纳洛酮敏感的伤害感受系统无关;然而,γ - 氨基丁酸(GABA)受体激活在蝇蕈醇这些作用中的作用仍有待阐明。

相似文献

1
Evaluation of the role of antinociception in self-injurious behavior following intranigral injection of muscimol.黑质内注射蝇蕈醇后抗伤害感受在自我伤害行为中的作用评估。
Neuropharmacology. 1986 Jul;25(7):717-26. doi: 10.1016/0028-3908(86)90087-0.
2
An investigation of the role played by the superior colliculus and ventromedial thalamus in self-injurious behavior produced by intranigral microinjection of muscimol.
Pharmacol Biochem Behav. 1987 Jan;26(1):187-9. doi: 10.1016/0091-3057(87)90553-3.
3
Involvement of the midbrain reticular formation in self-injurious behavior, stereotyped behavior, and analgesia induced by intranigral microinjection of muscimol.中脑网状结构参与黑质内微量注射蝇蕈醇诱导的自我伤害行为、刻板行为及镇痛作用。
Brain Res. 1986 Mar 26;369(1-2):231-42. doi: 10.1016/0006-8993(86)90532-9.
4
Self-injurious behavior in rats produced by intranigral microinjection of GABA agonists.
Pharmacol Biochem Behav. 1984 Jul;21(1):89-95. doi: 10.1016/0091-3057(84)90136-9.
5
Effects of bilateral injection of GABA into the substantia nigra on spontaneous behavior and measures of analgesia.双侧向黑质注射γ-氨基丁酸对自发行为和镇痛指标的影响。
Neuropharmacology. 1988 Aug;27(8):817-21. doi: 10.1016/0028-3908(88)90097-4.
6
Characterization of susceptibility to audiogenic seizures in ethanol-dependent rats after microinjection of gamma-aminobutyric acid (GABA) agonists into the inferior colliculus, substantia nigra or medial septum.乙醇依赖大鼠在向下丘、黑质或内侧隔微量注射γ-氨基丁酸(GABA)激动剂后对听源性惊厥易感性的特征分析。
J Pharmacol Exp Ther. 1983 Dec;227(3):663-70.
7
Involvement of the nigral output pathways in the inhibitory control of the substantia nigra over generalized non-convulsive seizures in the rat.黑质输出通路在大鼠黑质对全身性非惊厥性癫痫发作的抑制性控制中的作用。
Neuroscience. 1990;39(2):339-49. doi: 10.1016/0306-4522(90)90272-6.
8
Circling behavior induced by intranigral injections of GABA and muscimol in rats.大鼠黑质内注射γ-氨基丁酸和蝇蕈醇诱导的转圈行为
Psychopharmacology (Berl). 1980;68(1):31-6. doi: 10.1007/BF00426646.
9
Removal of the telencephalon spares turning induced by injection of GABA agonists and antagonists into the substantia nigra.去除端脑可使向黑质注射GABA激动剂和拮抗剂所诱导的旋转得以保留。
Behav Brain Res. 1980 Feb;1(1):25-38. doi: 10.1016/0166-4328(80)90044-3.
10
Contralateral turning evoked by the intranigral microinjection of muscimol and other GABA agonists.黑质内微量注射蝇蕈醇及其他GABA激动剂诱发的对侧转动
Brain Res. 1978 Oct 27;155(2):297-312. doi: 10.1016/0006-8993(78)91024-7.